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PRELIMINARY AND SHORT REPORT
PRODUCTION OF BULLAE IN PEMPHIGUS WITH HYALURONIDASE*
MELVIN L. CRAI5, M.D.
Since hyaluronidase was identified as a spreading factor and its role in hydrolysing the
hyaluronic acid of intercellular cement substance established, its effect in the formation of
bullae in pemphigus hss been a subject of speculation. The statement is frequently made
that the skin contains hyaluronidase. The reference upon which this statement is based is
the report of Meyer, et al (1). Evidence submitted by Glick and Grais (2) has questioned
the validity of this statement on the basis that hyalurouidase from bacterial contamina-
tion was not ruled out.
Mayer (3) found qoantitative increases of hyaluronidase in inflamed as against normal
skin and claims to have ruled out bacterial contamination.
Fin. 1. BULLAE Pfionucan BY INTEAnERMAL INJECTIONs OF HYALLTEONJnASE
Hunt and Miaot (4) with admittedly crude methods found no evidence which would in-
dicate that in pemphigus there is either an excessive amount of hyaluronidase or a defi-
ciency of hyaluronic acid in the skin.
MacCardle, Baumherger and Herald (5) postnlate that since hyaluronic acid binds
water holding it as a gel, hyaluronidase may produce bullae by hydrolysing the hyaluronie
acid leaving the water of the gel free as blister fluid at the site of the bulla.
Crais and Glick (6) found no hyaluronidase present in the bullous fluid of patients wit I
pemphigus.
This report describes the production of bullae in a case of advanced pemphigus by intra-
dermal injections of hyaluronidase. The same technic was unsuccessful in the next four
cases. While this is not a consistent finding, the effect in the successful case was so definite
and since the status of the disease in this patient was different from the other four it was
felt that it was worth reporting.
The patient was a 62 year old woman who ran an eleven week course from the appear-
ance of the first bulla to expiration. Twelve days before she expired, 0.05 cc. of a solution
of hyaluronidase1 containing 30 turbidity reducing units and 5 THU per cc. was injected
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1 Enzyme used was Hyronasc kindly supplied by Dr. W. Alan Wright of the Schering
Corporation. Samples of this enzyme were reassayed after the above experiments were com-
pleted. Three vials with stated potency of 150 THU each, assayed separately, were found
to contain 104, 82, and 87 THU. This is an average of 91 THU or 60% of stated potency.
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intradermally. Erythema soon developed in the injected areas. The next day the super-
ficial layer of skin appeared to be separating. In the next two days bnllae developed in
the injected areas (Fig. 1). The more superficial injections caused larger hullae. The
strength of the solution seemed less important. The bullae appeared nine days before the
patient expired.
Other areas were similarly injected with normal saline and with hyaluronidase which
had been inactivated hy treatment with heat. Nothing visible occurred in the area injected
with saline. Some redness and induration appeared in the area injected with heat-treated
hyaluronidase. No bullae appeared in these areas.
The subsequent four cases were men who had a much milder course of this disease. All
are living and in partial remission. No explanation for this phenomenon will be attempted
at this time. Perhaps further work will shed more light on the subject.
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